stoxline Quote Chart Rank Option Currency Glossary
  
Universe Pharmaceuticals INC (UPC)
2.3  0.01 (0.44%)    06-18 16:00
Open: 2.3
High: 2.3402
Volume: 5,831
  
Pre. Close: 2.29
Low: 2.3
Market Cap: 8(M)
Technical analysis
2024-06-18 4:49:31 PM
Short term     
Mid term     
Targets 6-month :  3.06 1-year :  3.49
Resists First :  2.62 Second :  2.99
Pivot price 2.42
Supports First :  2.03 Second :  1.69
MAs MA(5) :  2.3 MA(20) :  2.45
MA(100) :  2.06 MA(250) :  1.75
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  24.7 D(3) :  27.3
RSI RSI(14): 47.9
52-week High :  3 Low :  0.75
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ UPC ] has closed above bottom band by 36.5%. Bollinger Bands are 2.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.34 - 2.35 2.35 - 2.36
Low: 2.28 - 2.29 2.29 - 2.3
Close: 2.28 - 2.3 2.3 - 2.31
Company Description

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Headline News

Wed, 12 Jun 2024
Universe Pharmaceuticals (NYSE:UPC) Stock Price Down 5.7% - Defense World

Tue, 20 Feb 2024
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday - InvestorPlace

Tue, 20 Feb 2024
Why Is Gaxos.AI (GXAI) Stock Down 21% Today? - InvestorPlace

Tue, 20 Feb 2024
Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket - Markets Insider

Tue, 20 Feb 2024
Why Is Universe Pharmaceuticals (UPC) Stock Down 29% Today? - InvestorPlace

Thu, 27 Jul 2023
Universe Pharmaceuticals INC Announces Share Consolidation - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 4 (M)
Shares Float 2 (M)
Held by Insiders 57 (%)
Held by Institutions 0 (%)
Shares Short 18 (K)
Shares Short P.Month 4 (K)
Stock Financials
EPS -1.71
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 10.9
Profit Margin -19.1 %
Operating Margin -26.6 %
Return on Assets (ttm) -4 %
Return on Equity (ttm) -14.4 %
Qtrly Rev. Growth -13.2 %
Gross Profit (p.s.) 0
Sales Per Share 8.85
EBITDA (p.s.) -0.83
Qtrly Earnings Growth 0 %
Operating Cash Flow 1 (M)
Levered Free Cash Flow 2 (M)
Stock Valuations
PE Ratio -1.36
PEG Ratio 0
Price to Book value 0.21
Price to Sales 0.25
Price to Cash Flow 7.49
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android